TwinBeech Capital’s Cymabay Therapeutics CBAY Stock Holding History

TwinBeech Capital’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,230	Closed	-$265K	–	923
2023 Q4	$265K	Buy	+11,230	New	+$200K	﹤0.01%	589

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TwinBeech Capital's CBAY Position: Q1 2024 in Review

TwinBeech Capital sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 11,230 shares — an estimated $265K sold.

TwinBeech Capital first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $265K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

TwinBeech Capital reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
TwinBeech Capital sold 11,230 Cymabay Therapeutics shares in Q1 2024, an estimated $265K.
TwinBeech Capital first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
TwinBeech Capital's Cymabay Therapeutics position peaked at $265K in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on TwinBeech Capital's 13F filing for Q1 2024, filed 15 May 2024.